Medicine and Dentistry
Venetoclax
100%
Acute Myeloid Leukemia
100%
Programmed Cell Death
25%
THP1 Cell Line
16%
Hypomethylating Agent
16%
Cell Line
16%
Optimal Drug Dose
8%
Resistant Cell Line
8%
Hematological Cancer
8%
Antiapoptotic
8%
Cytarabine
8%
Acute Myeloid Leukemia Cell Line
8%
Myelodysplastic Syndrome
8%
Combination Drug
8%
Cancer Cell
8%
Targeted Therapy
8%
Real-Time Polymerase Chain Reaction
8%
IC50
8%
Cell Viability
8%
Low Drug Dose
8%
Dose Response
8%
Cell Death
8%
Western Blot
8%
Pharmacology, Toxicology and Pharmaceutical Science
Venetoclax
100%
Acute Myeloid Leukemia
100%
Malignant Neoplasm
16%
Myelodysplastic Syndrome
8%
Cytarabine
8%
Combination Drug
8%
Western Blot
8%
IC50
8%
Chemotherapy
8%
Cell Viability
8%
Antiapoptotic
8%